Nuclear Radiology: Page 86

PET dose-painting methods produce discordant results
By Kathlyn Stone
As intensity-modulated radiation therapy becomes more sophisticated, oncologists are investigating new dose-painting methods to determine which areas of tumor target volume should receive additional radiation dose. But a new study indicates that two promising methods to guide dose painting actually produce sharply varied results.
August 26, 2008
2008 08 26 13 24 26 219 Dose Plan Simonic Thumb
AECL monitors isotope supply after Dutch shutdown
By AuntMinnieEurope.com staff writers
Canadian isotope supplier Atomic Energy of Canada (AECL) is ready to increase production to cover a potential shortfall in isotope supply after the recent shutdown of a nuclear reactor in the Netherlands.
August 25, 2008
IBA, NeuroSurvival Technologies partner
By AuntMinnieEurope.com staff writers
Belgian radiopharmaceutical firm Ion Beam Applications (IBA) has signed a collaboration agreement with molecular imaging and therapy developer NeuroSurvival Technologies (NST).
August 13, 2008
Liver fat a key determinant of 'metabolically benign obesity'
By Reuters Health
NEW YORK (Reuters Health), Aug 12 - Close to one-third of obese individuals are "metabolically healthy" and at low risk for heart disease, whereas a quarter of normal-weight individuals are metabolically abnormal with numerous cardiac risk factors, according to two reports in the August 11/25 issue of the Archives of Internal Medicine.
August 11, 2008
Reuterslogo
PET with C-11 PiB can assess beta-amyloid brain deposits
By Erik L. Ridley
PET using carbon-11-labeled Pittsburgh Compound B (C-11 PiB) shows promise for assessing beta-amyloid deposits in the brain and may have a potential role as a diagnostic aid for early Alzheimer's disease, according to research published online in the Archives of Neurology.
August 11, 2008
Covidien sales rise in Q3
By AuntMinnieEurope.com staff writers
Broad-based growth in radiopharmaceuticals and contrast products propelled Covidien's Imaging Solutions business unit to an 18% increase in sales in its fiscal third quarter.
August 4, 2008
IBA, Lantheus ink radiopharma deal
By AuntMinnieEurope.com staff writers
Belgian radiopharmaceutical firm Ion Beam Applications (IBA) has signed an exclusive distribution deal with Lantheus Medical Imaging.
July 30, 2008
PET imaging reveals coronary vascular dysfunction in asymptomatic diabetics
By Reuters Health
NEW YORK (Reuters Health), Jun 24 - In a study of type 2 diabetics with no history or symptoms of heart disease, nearly all had evidence of coronary vascular dysfunction on PET imaging. Study results were presented in New Orleans at the 2008 SNM annual meeting.
June 23, 2008
Reuterslogo
French researchers develop handheld probe for SLN detection
By Wayne Forrest
NEW ORLEANS - Researchers from France have developed a handheld gamma camera to perform lymphoscintigraphy for sentinel lymph node (SLN) localization in breast cancer. They presented details of the device and results of a prospective clinical study comparing it with a conventional gamma camera during the 2008 SNM annual meeting.
June 16, 2008
IBA, Wilex ink licensing pact
By AuntMinnieEurope.com staff writers
Belgian radiopharmaceutical firm Ion Beam Applications (IBA) has signed a licensing agreement for the worldwide marketing, distribution, and sales of Redectane from Wilex of Munich, Germany.
June 5, 2008
IBA finalizes acquisition of CIS bio
By AuntMinnieEurope.com staff writers
Belgian radiopharmaceutical firm Ion Beam Applications (IBA) of Louvain-la-Neuve has moved to finalize its purchase of CIS bio International.
May 29, 2008
PETNet gets U.K. FDG license
By AuntMinnieEurope.com staff writers
Siemens Healthcare said that its PETNet Solutions division has received a full Marketing Authorization and Manufacturer's/Importer's (MIA) license to produce and distribute its FDG biomarker from its Nottingham City Hospital site.
May 11, 2008
Previous Page
Page 86 of 90
Next Page